首頁 > 市場調查報告書 > 醫療設備

核子醫學

市場調查報告書

商品編碼

1471971

質子治療系統市場規模和預測、全球和地區佔有率、趨勢和成長機會分析報告範圍：按設定類型、應用和地理位置

Proton Therapy Systems Market Size and Forecast, Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Setup Type, Application, and Geography

出版日期: 2024年03月13日 | 出版商:

The Insight Partners | 英文 150 Pages | 商品交期: 1-5個工作天內

價格

簡介目錄

質子治療系統市場規模預計將從2022年的12.6億美元成長到2030年的44.4億美元；預計2022年至2030年複合年成長率為17.0%。

質子治療系統市場的市場促進因素

癌症的高盛行率和對癌症先進治療的需求增加了對質子放射治療的需求，推動了質子治療系統市場的成長。根據國際癌症研究機構 (IARC) 的數據，2022 年肺癌、乳癌和攝護腺癌的發生率最高。根據IARC 的估計，癌症總病例數預計將從2022 年的1,998 萬例躍升至2030 年的2,371 萬例和2045 年的3,097 萬例。、和喉癌）和腦癌具有精確的治療要求，這導致對調強質子治療（IMPT）等先進治療方法的需求很高。在傳統的放射治療中，例如X光放射治療，腫瘤周圍的健康組織也會受到一定劑量的輻射，這會導致副作用並可能導致繼發性癌症。然而，質子治療有助於有效治療大腦、頭頸區域的複雜腫瘤，同時最大限度地減少對附近組織的附帶損害。因此，癌症的高盛行率和對先進治療的需求增加了對質子放射治療的需求，推動了質子治療系統市場的成長。

質子治療系統市場的機遇

印度、中國、阿根廷、巴西、阿拉伯聯合大公國和南非等新興國家預計將為質子治療系統市場參與者提供巨大的成長機會，因為可支配收入增加、癌症患者人口不斷增加、研發活動增加、醫療基礎設施改善、醫療保健基礎設施不斷成長、與已開發國家相比，人們對疾病的認知和指導方針相對寬鬆。這顯示質子治療系統市場的實力。隨著這些國家癌症發生率的上升，對各種質子療法和其他癌症治療方案的需求更大。此外，這些國家的政府正致力於增加更多人口獲得有效和尖端醫療服務的機會，並提高報銷範圍。人均醫療保健支出的快速成長以及公眾對負擔得起的醫療保健服務的需求不斷成長，推動了這些國家醫療保健產品（包括癌症治療設備）的擴張。例如，根據世界經濟論壇的數據，截至 2022 年，俄羅斯、巴西、中國、印度和南非合計佔全球衛生支出的三分之一。根據世界銀行的數據，2018年至2019年，印度和中國的醫療支出分別成長了3.01%和5.35%。時期。

質子治療系統市場：細分概述

市場依設定類型分為單間和多間。多房間細分市場在 2022 年佔據最大的市場佔有率，單房間細分市場預計在預測期內複合年成長率最高。質子治療系統市場依應用分為腦部及中樞神經系統癌症、頭頸癌、攝護腺癌、乳癌、肺癌、胃腸道癌症等。到 2022 年，大腦和中樞神經系統癌症領域將佔據最大的質子治療系統市場佔有率，預計在預測期內複合年成長率最高。

質子治療系統市場：地理概述

據估計，2022 年至 2030 年亞太地區的複合年成長率最高。印度和中國等亞太國家擁有質子治療系統市場的巨大成長潛力。 2022年，北美佔據最大的市場佔有率。最新醫療設備的日益接受和採用、癌症的高盛行率以及主要參與者的產品創新都有助於北美質子治療系統市場規模的擴大。根據美國癌症協會估計，2023 年美國新增約 195 萬癌症病例和約 61 萬癌症相關死亡病例，較 2020 年報告的 160 萬癌症病例和 60 萬死亡人數顯著增加。截至2023年底，美國擁有全球質子治療系統數量最多的國家，擁有46個質子治療設施。因此，癌症的高盛行率和質子治療系統的大量安裝有利於質子治療系統市場的發展。

在準備質子治療系統市場報告時提到的一些主要一手和二手來源包括世界銀行數據、國家醫療服務體系 (NHS)、FDA（食品和藥物管理局）、EMA（歐洲藥品管理局）和WHO（世界衛生組織）。

歐洲
- 德國
- 法國
- 義大利
- 西班牙
- 英國
- 歐洲其他地區
亞太
- 澳洲
- 中國
- 印度
- 日本
- 韓國
- 亞太其他地區
中東和非洲
- 南非
- 沙烏地阿拉伯
- 阿拉伯聯合大公國
- 中東和非洲其他地區
南美洲和中美洲
- 巴西
- 阿根廷
- 南美洲和中美洲其他地區

第 10 章：產業格局

併購
協議、合作、合資企業
新產品發布
擴張和其他策略發展

第 11 章：競爭格局

關鍵參與者的熱圖分析
公司定位與專注

第 12 章：質子治療系統市場 - 主要公司概況

Varian Medical Systems Inc
Hitachi Ltd
Sumitomo Heavy Industries Ltd
Ion Beam Applications SA
Mevion Medical Systems
Provision Healthcare LLC
ProTom International
Optivus Proton Therapy Inc
Advanced Oncotherapy plc
B dot Medical Inc

第 13 章：附錄

簡介目錄

Product Code: TIPHE100001160

The proton therapy systems market size is expected to grow from US$ 1.26 billion in 2022 to US$ 4.44 billion by 2030; it is anticipated to record a CAGR of 17.0% from 2022 to 2030.

Market Drivers of the Proton Therapy Systems Market

The high prevalence of cancer and demand for advanced treatments for cancers boost the demand for proton-based radiotherapy, fueling the proton therapy systems market growth. As per the International Agency for Research on Cancer (IARC), lung, breast, and prostate cancer types had the highest incidence rate in 2022. These diseases have an age-standardized rate of 23.6, 47.1, and 29.4 cases per 100,000 population, respectively. According to the estimates by IARC, the number of total cancer cases is expected to jump from 19.98 million in 2022 to 23.71 million by 2030 and 30.97 million by 2045. Various cancer conditions, such as head and neck cancers (nasal, oral, eye, and larynx) and brain cancers have precise treatment requirements, which results in a high demand for advanced treatment approaches such as intensity-modulated proton therapy (IMPT). In traditional radiation therapies, such as X-ray radiation therapy, the healthy tissue around the tumor also receives a dose of radiation, which leads to side effects and may cause secondary cancers. However, proton therapy aids in the effective treatment of complicated tumors in the brain, and head and neck region while minimizing the collateral damage to nearby tissues. Thus, the high prevalence of cancer and demand for advanced treatments boost the demand for proton-based radiotherapy, fueling the proton therapy systems market growth.

Opportunities in the Proton Therapy Systems Market

Emerging countries such as India, China, Argentina, Brazil, UAE, and South Africa are expected to offer significant growth opportunities for proton therapy systems market players due to rising disposable incomes, expanding cancer patient population, increasing R&D activities, improving healthcare infrastructure, growing disease awareness, and relatively lenient guidelines compared to developed countries. This is an indication of strength in the proton therapy systems market. As cancer incidence rises in these countries, there is a greater demand for various proton therapy and other cancer treatment options. Furthermore, the governments of these countries are focusing on increasing access to effective and cutting-edge healthcare services for a larger proportion of their populations and improving reimbursement coverage. The expansion of healthcare products (including cancer treatment devices) across these nations is driven by the quick increase in per-capita healthcare spending and the growing public demand for affordable healthcare services. For instance, According to the World Economic Forum, as of 2022, Russia, Brazil, China, India, and South Africa collectively accounted for a third of global health spending. As per the World Bank, health spending in India and China increased by 3.01% and 5.35%, respectively, from 2018 to 2019. Thus, the increasing healthcare expenditure in emerging countries will likely provide opportunities for the proton therapy systems market growth during the forecast period.

Proton Therapy Systems Market: Segmental Overview

The market is bifurcated by setup type into single room and multi room. The multi room segment held the largest market share in 2022 and single room segment is anticipated to register the highest CAGR during the forecast period. The proton therapy systems market, by application, is categorized into brain and central nervous system cancer, head and neck cancer, prostate cancer, breast cancer, lung cancer, gastrointestinal cancer, and others. The brain and central nervous system cancer segment held the largest proton therapy systems market share in 2022 and it is anticipated to register the highest CAGR during the forecast period.

Proton Therapy Systems Market: Geographical Overview

Asia Pacific is estimated to register the highest CAGR during 2022-2030. Countries in the Asia Pacific, such as India and China, hold significant potential for the growth of the proton therapy systems market. In 2022, North America accounted for the largest market share. The growing acceptance and adoption of the latest medical devices, the high prevalence of cancer, and product innovations by key players contribute to the expansion of the proton therapy systems market size in North America. According to the American Cancer Society estimates, the US recorded ~1.95 million new cancer cases and ~0.61 million mortalities related to the disease in 2023, exhibiting a significant increase from 1.60 million cancer cases and 0.60 million deaths reported in 2020. As per the Particle Therapy Co-Operative Group, at the end of 2023, the US had the highest number of proton therapy systems globally, with 46 proton therapy treatment facilities. Thus, the high prevalence of cancer and the high number of installed proton therapy systems favor the proton therapy systems market progress.

A few of the major primary and secondary sources referred to while preparing the report on the proton therapy systems market are the World Bank Data, National Health Service (NHS), FDA (Food and Drug Administration), EMA (European Medicines Agency), and WHO (World Health Organization).

1. Introduction

1.1 Scope of the Study
1.2 Market Definition, Assumptions and Limitations
1.3 Market Segmentation

2. Executive Summary

2.1 Key Insights
2.2 Market Attractiveness Analysis

3. Research Methodology

4. Proton Therapy Systems Market Landscape

4.1 Overview
4.2 PEST Analysis
4.3 Ecosystem Analysis
- 4.3.1 List of Vendors in the Value Chain

5. Proton Therapy Systems Market - Key Market Dynamics

5.1 Key Market Drivers
5.2 Key Market Restraints
5.3 Key Market Opportunities
5.4 Future Trends
5.5 Impact Analysis of Drivers and Restraints

6. Proton Therapy Systems Market - Global Market Analysis

6.1 Proton Therapy Systems - Global Market Overview
6.2 Proton Therapy Systems - Global Market and Forecast to 2030

7. Proton Therapy Systems Market - Revenue Analysis (USD Million) - By Set-up Type, 2020-2030

7.1 Overview
7.2 Single Room
7.3 Multi Room

8. Proton Therapy Systems Market - Revenue Analysis (USD Million) - By Application, 2020-2030

8.1 Overview
8.2 Brain and Central Nervous System Cancer
8.3 Head and Neck Cancer
8.4 Prostate Cancer
8.5 Breast Cancer
8.6 Lung Cancer
8.7 Gastrointestinal Cancer
8.8 Others

9. Proton Therapy Systems Market - Revenue Analysis (USD Million), 2020-2030 - Geographical Analysis

9.1 North America
- 9.1.1 North America Proton Therapy Systems Market Overview
- 9.1.2 North America Proton Therapy Systems Market Revenue and Forecasts to 2030
- 9.1.3 North America Proton Therapy Systems Market Revenue and Forecasts and Analysis - By Set-up Type
- 9.1.4 North America Proton Therapy Systems Market Revenue and Forecasts and Analysis - By Application
- 9.1.5 North America Proton Therapy Systems Market Revenue and Forecasts and Analysis - By Countries
  - 9.1.5.1 United States Proton Therapy Systems Market
    - 9.1.5.1.1 United States Proton Therapy Systems Market, by Set-up Type
    - 9.1.5.1.2 United States Proton Therapy Systems Market, by Application
  - 9.1.5.2 Canada Proton Therapy Systems Market
    - 9.1.5.2.1 Canada Proton Therapy Systems Market, by Set-up Type
    - 9.1.5.2.2 Canada Proton Therapy Systems Market, by Application
  - 9.1.5.3 Mexico Proton Therapy Systems Market
    - 9.1.5.3.1 Mexico Proton Therapy Systems Market, by Set-up Type
    - 9.1.5.3.2 Mexico Proton Therapy Systems Market, by Application

Note - Similar analysis would be provided for below mentioned regions/countries

9.2 Europe
- 9.2.1 Germany
- 9.2.2 France
- 9.2.3 Italy
- 9.2.4 Spain
- 9.2.5 United Kingdom
- 9.2.6 Rest of Europe
9.3 Asia-Pacific
- 9.3.1 Australia
- 9.3.2 China
- 9.3.3 India
- 9.3.4 Japan
- 9.3.5 South Korea
- 9.3.6 Rest of Asia-Pacific
9.4 Middle East and Africa
- 9.4.1 South Africa
- 9.4.2 Saudi Arabia
- 9.4.3 U.A.E
- 9.4.4 Rest of Middle East and Africa
9.5 South and Central America
- 9.5.1 Brazil
- 9.5.2 Argentina
- 9.5.3 Rest of South and Central America

10. Industry Landscape

10.1 Mergers and Acquisitions
10.2 Agreements, Collaborations, Joint Ventures
10.3 New Product Launches
10.4 Expansions and Other Strategic Developments

11. Competitive Landscape

11.1 Heat Map Analysis by Key Players
11.2 Company Positioning and Concentration

12. Proton Therapy Systems Market - Key Company Profiles

12.1 Varian Medical Systems Inc
- 12.1.1 Key Facts
- 12.1.2 Business Description
- 12.1.3 Products and Services
- 12.1.4 Financial Overview
- 12.1.5 SWOT Analysis
- 12.1.6 Key Developments

Note - Similar information would be provided for below list of companies